MMS is collaborating with the DIA for an upcoming complimentary webinar, “Optimizing the Use of Clinical Trial Disclosure Systems to Meet Complex and Evolving Global Regulatory Requirements.”
Learning Objectives
- Determine key drivers for the use of technology to manage clinical trial disclosures processes
- Implement efficiencies and consistencies gained from enabling reuse of protocol and results summary content across regions
- Understand the importance of integrating drug and submission-level metrics into disclosures systems
- Identify system features and functionality that are key to achieving global compliance
- Recognize the importance of automated workflow management to manage the disclosures life cycle
Presenters
- Kasim McLain, Manager, Disclosure Services, MMS
- Peggy Zorn, MS, MBA, Associate Director, Regulatory Affairs, Submissions and Transparency, MMS
- Gitta Irmer, MS, Associate Director, Data Quality and Standards, Eisai
- Zach Weingarden, MS, Product Solutions Manager, TrialAssure
